"During the three months ended June 30, 2014, we sold our interest in our previously entered into Bio-Tech Medical Software transaction and our interest in our MedVend Holding transaction to the affiliate of our co-founder for shares of common stock was approximately $1.2 million. The 50,000 shares of common stocks received are currently reflected as treasury stock." http://seekingalpha.com/article/2433395-medboxs-mdbx-ceo-guy-marsala-on-q2-2014-results-earnings-call-transcript?page=4
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.